# Registry of Asthma Patients Initiating DUPIXENT®

> **NCT04287621** · — · ACTIVE_NOT_RECRUITING · sponsor: **Regeneron Pharmaceuticals** · enrollment: 718 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** DUPIXENT®

## Key facts

- **NCT ID:** NCT04287621
- **Lead sponsor:** Regeneron Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-03-02
- **Primary completion:** 2026-04-27
- **Final completion:** 2026-04-27
- **Target enrollment:** 718 (ACTUAL)
- **Last updated:** 2026-02-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04287621

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04287621, "Registry of Asthma Patients Initiating DUPIXENT®". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT04287621. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*